Seminars in Oncology Nursing
Volume 20, Issue 1 , Pages 38-47, February 2004

Gastrointestinal mucositis☆

Abstract 

To review the management of radiotherapy- and chemotherapy-induced gastrointestinal mucositis.

Articles and research studies.

Gastrointestinal damage is becoming a common dose-limiting toxicity. However, there is only limited research into the mechanism and possible treatment of this toxicity.

It is important to document the frequency and severity of gastrointestinal mucositis, and to alleviate symptoms wherever possible.

To access this article, please choose from the options below

Login to an existing account or Register a new account.

  • Purchase this article for 12.00 USD (You must login/register to purchase this article)

    Online access for 24 hours. The PDF version can be downloaded as your permanent record.

  • Subscribe to this title

    Get unlimited online access to this article and all other articles in this title 24/7 for one year.

  • Claim access now

    For current subscribers with Society Membership or Account Number.

  • Visit SciVerse ScienceDirect to see if you have access via your institution.
 

☆ Supported by National Institutes of Health grant nos. CA83719 (M.H.-J.) and CA71382 (M.H.-J.) and the Cancer Council of South Australia (D.M.K.). In addition, support was provided by Amgen (KGF to D.M.K. and R.J.G.) and Pharmacia (Irinotecan to D.M.K. and R.J.G.).

PII: S0749-2081(03)00138-4

doi:10.1053/j.soncn.2003.10.007

Seminars in Oncology Nursing
Volume 20, Issue 1 , Pages 38-47, February 2004

Article Tools